CKDkb: a knowledge base and platform for drug development against non-alcoholic fatty liver disease

Clinical Trial Details

Trial ID:	L3132
Source ID:	NCT00184574
Associated Drug:	Biphasic Insulin Aspart
Title:	Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes
Acronym:
Status:	COMPLETED
Study Results:	NO
Results:
Conditions:	Diabetes\|Diabetes Mellitus, Type 2
Interventions:	DRUG: biphasic insulin aspart\|DRUG: metformin
Outcome Measures:	Primary: HbA1c, after 36 weeks \| Secondary: 8-point plasma glucose profiles\|Safety variables\|Other glycemic variables
Sponsor/Collaborators:	Sponsor: Novo Nordisk A/S
Gender:	ALL
Age:	ADULT, OLDER_ADULT
Phases:	PHASE3
Enrollment:	603
Study Type:	INTERVENTIONAL
Study Designs:	Allocation: RANDOMIZED\|Intervention Model: SINGLE_GROUP\|Masking: NONE\|Primary Purpose: TREATMENT
Start Date:	2005-04
Completion Date:	2006-03
Results First Posted:
Last Update Posted:	2017-01-05
Locations:	Novo Nordisk Investigational Site, Bregenz, A - 6900, Austria\|Novo Nordisk Investigational Site, Feldkirch, 6807, Austria\|Novo Nordisk Investigational Site, Graz, 8036, Austria\|Novo Nordisk Investigational Site, Salzburg, 5010, Austria\|Novo Nordisk Investigational Site, Wien, A-1130, Austria\|Novo Nordisk Investigational Site, Bonheiden, 2820, Belgium\|Novo Nordisk Investigational Site, Brussels, 1070, Belgium\|Novo Nordisk Investigational Site, Genk, 3600, Belgium\|Novo Nordisk Investigational Site, Gent, 9000, Belgium\|Novo Nordisk Investigational Site, Liège, 4000, Belgium\|Novo Nordisk Investigational Site, Pleven, 5800, Bulgaria\|Novo Nordisk Investigational Site, Sofia, 1431, Bulgaria\|Novo Nordisk Investigational Site, Brno, 65691, Czech Republic\|Novo Nordisk Investigational Site, Hradec Králové, 500 36, Czech Republic\|Novo Nordisk Investigational Site, Praha 5, 15018, Czech Republic\|Novo Nordisk Investigational Site, Køge, 4600, Denmark\|Novo Nordisk Investigational Site, Odense, 5000, Denmark\|Novo Nordisk Investigational Site, Århus C, 8000, Denmark\|Novo Nordisk Investigational Site, Antibes, 06600, France\|Novo Nordisk Investigational Site, Boulogne-billancourt, 92100, France\|Novo Nordisk Investigational Site, Brest, 29609, France\|Novo Nordisk Investigational Site, LA ROCHELLE cedex, 17019, France\|Novo Nordisk Investigational Site, Le Chesnay, 78150, France\|Novo Nordisk Investigational Site, Lille, 59037, France\|Novo Nordisk Investigational Site, Metz, 57000, France\|Novo Nordisk Investigational Site, Mougins, 06250, France\|Novo Nordisk Investigational Site, Narbonne, 11108, France\|Novo Nordisk Investigational Site, NEVERS cedex, 58033, France\|Novo Nordisk Investigational Site, PERPIGNAN cedex, 66046, France\|Novo Nordisk Investigational Site, Bad Heilbrunn, 83670, Germany\|Novo Nordisk Investigational Site, Beckum, 59269, Germany\|Novo Nordisk Investigational Site, Berlin, 10318, Germany\|Novo Nordisk Investigational Site, Dormagen, 41539, Germany\|Novo Nordisk Investigational Site, Dresden, 01219, Germany\|Novo Nordisk Investigational Site, Duisburg, 47259, Germany\|Novo Nordisk Investigational Site, Genthin, 39307, Germany\|Novo Nordisk Investigational Site, Kippenheim, 77971, Germany\|Novo Nordisk Investigational Site, München, 81479, Germany\|Novo Nordisk Investigational Site, Pohlheim, 35415, Germany\|Novo Nordisk Investigational Site, Saarbrücken, 66121, Germany\|Novo Nordisk Investigational Site, Schönebeck, 39218, Germany\|Novo Nordisk Investigational Site, St. Ingbert, 66386, Germany\|Novo Nordisk Investigational Site, Völklingen, 66333, Germany\|Novo Nordisk Investigational Site, Würzburg, 97072, Germany\|Novo Nordisk Investigational Site, Budapest, 1125, Hungary\|Novo Nordisk Investigational Site, Debrecen, 4043, Hungary\|Novo Nordisk Investigational Site, Veszprem, 8200, Hungary\|Novo Nordisk Investigational Site, Catania, 95126, Italy\|Novo Nordisk Investigational Site, Firenze, 50141, Italy\|Novo Nordisk Investigational Site, Gazi, 98124, Italy\|Novo Nordisk Investigational Site, Lucca, 55100, Italy\|Novo Nordisk Investigational Site, Milano, 20157, Italy\|Novo Nordisk Investigational Site, Padova, 35143, Italy\|Novo Nordisk Investigational Site, Roma, 00133, Italy\|Novo Nordisk Investigational Site, Roma, 00195, Italy\|Novo Nordisk Investigational Site, Salerno, 84125, Italy\|Novo Nordisk Investigational Site, Savigliano (CN), 12038, Italy\|Novo Nordisk Investigational Site, Terni, 05100, Italy\|Novo Nordisk Investigational Site, Udine, 33100, Italy\|Novo Nordisk Investigational Site, Amersfoort, 3816 CP, Netherlands\|Novo Nordisk Investigational Site, Brunssum, 6442 BE, Netherlands\|Novo Nordisk Investigational Site, Den Bosch, 5223 GV, Netherlands\|Novo Nordisk Investigational Site, Hoogeveen, 7909 AA, Netherlands\|Novo Nordisk Investigational Site, Roosendaal, 4708 AE, Netherlands\|Novo Nordisk Investigational Site, Rotterdam, 3011 TD, Netherlands\|Novo Nordisk Investigational Site, Lublin, 20-538, Poland\|Novo Nordisk Investigational Site, Mazowieckie, 09-400, Poland\|Novo Nordisk Investigational Site, Poznan, 61-696, Poland\|Novo Nordisk Investigational Site, Szczecin, 71-455, Poland\|Novo Nordisk Investigational Site, Warsaw, 01-911, Poland\|Novo Nordisk Investigational Site, Zabrze, 41-800, Poland\|Novo Nordisk Investigational Site, Ploiesti, Prahova, 100097, Romania\|Novo Nordisk Investigational Site, Galati, 800578, Romania\|Novo Nordisk Investigational Site, Suceava, 720062, Romania\|Novo Nordisk Investigational Site, Targu-Mures, 540061, Romania\|Novo Nordisk Investigational Site, Moscow, 117036, Russian Federation\|Novo Nordisk Investigational Site, Moscow, 123448, Russian Federation\|Novo Nordisk Investigational Site, Moscow, 127644, Russian Federation\|Novo Nordisk Investigational Site, Saint-Petersburg, 194354, Russian Federation\|Novo Nordisk Investigational Site, Saint-Petersburg, 198013, Russian Federation\|Novo Nordisk Investigational Site, Ljubljana, 1000, Slovenia\|Novo Nordisk Investigational Site, Albacete, 02006, Spain\|Novo Nordisk Investigational Site, Granada, 18012, Spain\|Novo Nordisk Investigational Site, Hospitalet de Llobregat, 08907, Spain\|Novo Nordisk Investigational Site, Madrid, 28040, Spain\|Novo Nordisk Investigational Site, Madrid, 28046, Spain\|Novo Nordisk Investigational Site, Mostoles - Madrid -, 28935, Spain\|Novo Nordisk Investigational Site, Palma de Mallorca, 07014, Spain\|Novo Nordisk Investigational Site, San Juan, 03550, Spain\|Novo Nordisk Investigational Site, Valencia, 46014, Spain\|Novo Nordisk Investigational Site, Zaragoza, 50009, Spain\|Novo Nordisk Investigational Site, Biel, 2502, Switzerland\|Novo Nordisk Investigational Site, Interlaken-Unterseen, 3800, Switzerland\|Novo Nordisk Investigational Site, St. Gallen, 9000, Switzerland\|Novo Nordisk Investigational Site, Winterthur, 8400, Switzerland\|Novo Nordisk Investigational Site, Zürich, 8002, Switzerland\|Novo Nordisk Investigational Site, Ankara, 06630, Turkey\|Novo Nordisk Investigational Site, Bursa, 16059, Turkey\|Novo Nordisk Investigational Site, Istanbul, 34098, Turkey\|Novo Nordisk Investigational Site, Bradford, BD9 6RJ, United Kingdom\|Novo Nordisk Investigational Site, Brighton, BN2 5BE, United Kingdom\|Novo Nordisk Investigational Site, Bristol, BS10 5NB, United Kingdom\|Novo Nordisk Investigational Site, Cosham, PO6 3LY, United Kingdom\|Novo Nordisk Investigational Site, Dundee, DD1 9SY, United Kingdom\|Novo Nordisk Investigational Site, Plymouth, PL8 8DQ, United Kingdom\|Novo Nordisk Investigational Site, Salford, M6 8HD, United Kingdom\|Novo Nordisk Investigational Site, Sheffield, S5 7AU, United Kingdom\|Novo Nordisk Investigational Site, Watford, WD18 0HB, United Kingdom
URL:	https://clinicaltrials.gov/show/NCT00184574

Knowledge Graph
Associated Data

Drug ID	Drug Name	Type	DrugBank ID	Targets	Category	Latest Progress
D089	Metformin	small molecule	DB00331				Details

Clinical Trial Details

Summary

Knowledge Graph

Associated Data

Associated NAFLD Drugs (1)